Editorial: Closing in on the Role of Thymic Stromal Lymphopoietin Inhibition as a Therapeutic Entry Point for Systemic Sclerosis

Alsya J Affandi, Joel A G van Roon

Research output: Contribution to journalArticleAcademic

Original languageEnglish
Pages (from-to)2571-2574
Number of pages4
JournalArthritis & rheumatology
Volume68
Issue number11
DOIs
Publication statusPublished - Nov 2016

Cite this